Buy Divis Labs, go long in IRB Infra: Rahul Mohindar

Rahul Mohindar of viratechindia.com told CNBC-TV18, "Sectorally we are bullish on pharmaceutical space. Divis Laboratories has corrected in the last seven-eight trading sessions. When you look at volumes along with the price move, we have seen a declining trend in price, a declining trend in volume and all that goes with a fact that in the long term there is strength. People could use these corrections to get into Divi's Lab. We are looking at new highs coming in. So with Rs 1,870 as stop loss we are looking at a buy on Divis with target atRs 2,010-2,020.""IRB Infrastructure Developers has been consolidating. If we look at data from July-August 2014 till now, the stock has not done too much. It has been fairly range bound. The sweet spot to get into IRB has always been around Rs 220-240 range," he said."At the current level or around Rs 240 it is a good point to enter the stock. We like the IRB Infra for long term but I am taking a trailing call here with a stop loss at Rs 234. One could look at long positions for targets of Rs 252."